Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 3
1992 1
1993 1
1994 2
1996 1
1997 2
1998 5
1999 3
2000 3
2001 3
2002 4
2003 7
2004 1
2005 4
2006 10
2007 6
2008 8
2009 7
2010 10
2011 12
2012 16
2013 9
2014 6
2015 11
2016 11
2017 8
2018 2
2019 5
2020 6
2021 15
2022 14
2023 14
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

179 results

Results by year

Filters applied: . Clear all
Page 1
Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B.
Pipe SW, Leebeek FWG, Recht M, Key NS, Castaman G, Miesbach W, Lattimore S, Peerlinck K, Van der Valk P, Coppens M, Kampmann P, Meijer K, O'Connell N, Pasi KJ, Hart DP, Kazmi R, Astermark J, Hermans CRJR, Klamroth R, Lemons R, Visweshwar N, von Drygalski A, Young G, Crary SE, Escobar M, Gomez E, Kruse-Jarres R, Quon DV, Symington E, Wang M, Wheeler AP, Gut R, Liu YP, Dolmetsch RE, Cooper DL, Li Y, Goldstein B, Monahan PE. Pipe SW, et al. Among authors: astermark j. N Engl J Med. 2023 Feb 23;388(8):706-718. doi: 10.1056/NEJMoa2211644. N Engl J Med. 2023. PMID: 36812434 Clinical Trial.
International consensus recommendations on the management of people with haemophilia B.
Hart DP, Matino D, Astermark J, Dolan G, d'Oiron R, Hermans C, Jiménez-Yuste V, Linares A, Matsushita T, McRae S, Ozelo MC, Platton S, Stafford D, Sidonio RF Jr, Tiede A. Hart DP, et al. Among authors: astermark j. Ther Adv Hematol. 2022 Apr 2;13:20406207221085202. doi: 10.1177/20406207221085202. eCollection 2022. Ther Adv Hematol. 2022. PMID: 35392437 Free PMC article. Review.
Subcutaneous concizumab prophylaxis in hemophilia A and hemophilia A/B with inhibitors: phase 2 trial results.
Shapiro AD, Angchaisuksiri P, Astermark J, Benson G, Castaman G, Chowdary P, Eichler H, Jiménez-Yuste V, Kavakli K, Matsushita T, Poulsen LH, Wheeler AP, Young G, Zupancic-Salek S, Oldenburg J. Shapiro AD, et al. Among authors: astermark j. Blood. 2019 Nov 28;134(22):1973-1982. doi: 10.1182/blood.2019001542. Blood. 2019. PMID: 31444162 Free PMC article. Clinical Trial.
Overview of inhibitors.
Astermark J. Astermark J. Semin Hematol. 2006 Apr;43(2 Suppl 4):S3-7. doi: 10.1053/j.seminhematol.2006.03.006. Semin Hematol. 2006. PMID: 16690373 Review.
FVIII inhibitors: pathogenesis and avoidance.
Astermark J. Astermark J. Blood. 2015 Mar 26;125(13):2045-51. doi: 10.1182/blood-2014-08-535328. Epub 2015 Feb 23. Blood. 2015. PMID: 25712994 Free PMC article. Review.
Clinical issues in inhibitors.
Astermark J, Santagostino E, Keith Hoots W. Astermark J, et al. Haemophilia. 2010 Jul;16 Suppl 5:54-60. doi: 10.1111/j.1365-2516.2010.02294.x. Haemophilia. 2010. PMID: 20590857 Review.
Managing haemophilia for life: 4th Haemophilia Global Summit.
Astermark J, Dolan G, Hilberg T, Jiménez-Yuste V, Laffan M, Lassila R, Lobet S, Martinoli C, Perno CF. Astermark J, et al. Haemophilia. 2014 Jul;20 Suppl 5:1-20. doi: 10.1111/hae.12468. Haemophilia. 2014. PMID: 24924596
179 results